Wu, P, Haththotuwa, R, Kwok, CS, Babu, A, Kontronias, R, Rushton, C, Zaman, A, Fryer, AA, Kadam, U, Chew-Graham, CA and Mamas, M (2017) Pre-eclampsia and future cardiovascular health: a systematic review and meta-analysis. Circulation: Cardiovascular Quality and Outcomes, 10 (2). ISSN 1941-7713

[thumbnail of Supplementary table R2.pdf]
Supplementary table R2.pdf - Supplemental Material
Available under License Creative Commons Attribution Non-commercial.

Download (236kB) | Preview
[thumbnail of Manuscript-R2 submitted-clean.pdf]
Manuscript-R2 submitted-clean.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (426kB) | Preview


Preeclampsia is a pregnancy-specific disorder resulting in hypertension and multiorgan dysfunction. There is growing evidence that these effects persist after pregnancy. We aimed to systematically evaluate and quantify the evidence on the relationship between preeclampsia and the future risk of cardiovascular diseases.

Methods and Results—
We studied the future risk of heart failure, coronary heart disease, composite cardiovascular disease, death because of coronary heart or cardiovascular disease, stroke, and stroke death after preeclampsia. A systematic search of MEDLINE and EMBASE was performed to identify relevant studies. We used random-effects meta-analysis to determine the risk. Twenty-two studies were identified with >6.4 million women including >258 000 women with preeclampsia. Meta-analysis of studies that adjusted for potential confounders demonstrated that preeclampsia was independently associated with an increased risk of future heart failure (risk ratio [RR], 4.19; 95% confidence interval [CI], 2.09–8.38), coronary heart disease (RR, 2.50; 95% CI, 1.43–4.37), cardiovascular disease death (RR, 2.21; 95% CI, 1.83–2.66), and stroke (RR, 1.81; 95% CI, 1.29–2.55). Sensitivity analyses showed that preeclampsia continued to be associated with an increased risk of future coronary heart disease, heart failure, and stroke after adjusting for age (RR, 3.89; 95% CI, 1.83–8.26), body mass index (RR, 3.16; 95% CI, 1.41–7.07), and diabetes mellitus (RR, 4.19; 95% CI, 2.09–8.38).

Preeclampsia is associated with a 4-fold increase in future incident heart failure and a 2-fold increased risk in coronary heart disease, stroke, and death because of coronary heart or cardiovascular disease. Our study highlights the importance of lifelong monitoring of cardiovascular risk factors in women with a history of preeclampsia.

Item Type: Article
Additional Information: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Lippincott Williams & Wilkins Ltd. at http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003497 - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: preeclampsia, cardiovascular disease, risk factors, pregnancy, women
Subjects: R Medicine > RC Internal medicine > RC666 Diseases of the circulatory (Cardiovascular) system
R Medicine > RG Gynecology and obstetrics
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 25 Jan 2017 11:55
Last Modified: 29 Mar 2019 14:07
URI: https://eprints.keele.ac.uk/id/eprint/2820

Actions (login required)

View Item
View Item